Literature DB >> 2877954

Pharmacokinetics of tiadipone: a new anxiolytic.

F Gonzalez López, E L Mariño, A Dominguez-Gil.   

Abstract

In this study 10 healthy volunteers received a single oral dose of 25 mg of tiadipone in coated tablets. The levels of drug in plasma sample of each of the healthy volunteers were determined by a reverse phase HPLC technique. The evolution of the plasma levels of tiadipone with time after oral administration follows a single compartment open kinetic model. The absorption process showed wide interindividual differences with a mean value for the lag time of 0.76 +/- 0.28 h. Tiadipone reaches a maximum plasma concentration with a mean value of 386 ng/ml (range 338-498) between 1 and 3 h after administration. The elimination phase of the drug was seen to be monoexponential. The elimination half-life has a mean value of 3.34 +/- 1.16 h, lower than that established for other benzodiazepines in clinical practice.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2877954

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  3 in total

Review 1.  Bayesian parameter estimation and population pharmacokinetics.

Authors:  A H Thomson; B Whiting
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

Review 2.  'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports.

Authors:  Laura Orsolini; John M Corkery; Stefania Chiappini; Amira Guirguis; Alessandro Vento; Domenico De Berardis; Duccio Papanti; Fabrizio Schifano
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

3.  2-Amino-4,5-dihydrothiophene-3-carbonitriles: A New Synthesis, Quantum Chemical Studies, and Mannich-Type Reactions Leading to New Hexahydrothieno[2,3-d]pyrimidines.

Authors:  Victor V Dotsenko; Alexander V Bespalov; Arthur S Vashurin; Nicolai A Aksenov; Inna V Aksenova; Elena A Chigorina; Sergey G Krivokolysko
Journal:  ACS Omega       Date:  2021-11-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.